ADIPOQ and pancreatic neoplasm: Our previous study reported that adiponectin as well as its receptor mimetic, AdipoRon, can effectively inhibit proliferation and induce apoptosis in pancreatic cancer cell lines, albeit at concentrations greater than 25 μM [10].